Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Argentine hemorrhagic fever vaccine candidate
- Development stage
- Preclinical
- Lead developer
- SINERGIUM Biotech
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Argentine hemorrhagic fever vaccine candidate is a recombinant protein vaccine being developed by SINERGIUM Biotech for the prevention of Argentine Hemorrhagic Fever (AHF). The vaccine is produced using a baculovirus/insect-cell expression system to generate viral antigens intended to trigger a protective immune response against the Junín virus (JUNV), the causative agent of AHF. Currently in the preclinical research stage, the program is part of SINERGIUM's Open Innovation initiative, which involves collaborations with academic institutions to develop a modern recombinant alternative to existing live-attenuated vaccines for this endemic South American viral disease.
- Other names
- AHF vaccine candidateJunín virus vaccine candidate
02
Targets
Junín virus glycoprotein complex (GPC)
Beyond the preview
Go deeper on Argentine hemorrhagic fever vaccine candidate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Argentine hemorrhagic fever vaccine candidate.